Glioblastoma Model Using Human Cerebral Organoids

Area of Science:

• Neuroscience
• Oncology
• Biotechnology

Background:

• Glioblastoma (GBM) is an aggressive brain tumor with limited treatment options.
• Developing accurate models for studying GBM initiation and progression is crucial for therapeutic development.

Purpose of the Study:

• To establish a human cerebral organoid model for observing glioma initiation and invasion.
• To characterize the phenotype and gene expression of organoid-derived GBM cells.
• To validate the organoid system as a platform for GBM research.

Main Methods:

• CRISPR/Cas9 gene editing was used to introduce oncogenic mutations (HRasG12V) into human cerebral organoids.
• Tumor initiation, invasion, and organoid destruction were monitored microscopically.
• Orthotopic xenotransplantation into immunodeficient mice was performed.
• Gene expression profiling was used to compare organoid-derived tumors with human GBM subtypes.
• Human GBM cell lines were transplanted into cerebral organoids.

Main Results:

• Transformed cells in organoids rapidly became invasive, destroying surrounding structures.
• Organoid-derived tumor cells exhibited an invasive phenotype upon xenotransplantation.
• Gene expression profiles of organoid tumors resembled the mesenchymal subtype of human glioblastoma.
• Transplantation of GBM cell lines into organoids created invasive tumor-like structures.

Conclusions:

• Human cerebral organoids provide a viable platform for modeling glioma initiation and invasion.
• This model recapitulates key malignant features of glioblastoma.
• The organoid system holds potential for pre-clinical testing of cancer phenotypes and therapies.